Recent News

• 12.05.2025 - Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
• 12.01.2025 - Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
• 11.24.2025 - Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
• 11.17.2025 - Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Recent Filings

• 12.05.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.04.2025 - EFFECT Notice of Effectiveness
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.01.2025 - 8-K Current report
• 12.01.2025 - EX-99.1 EX-99.1
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.01.2025 - 253G2 253G2